Our Team

Dr. Anand Burman, who holds a Ph.D. in Pharmaceutical Chemistry from the University of Kansas, is a distinguished leader in the business and healthcare sectors. As the former Chairman of Dabur India Ltd., one of India's largest and oldest FMCG companies, Dr. Burman has played a monumental role in shaping the company’s legacy and growth. His extensive expertise and visionary leadership have left an indelible mark on the industry, both in India and globally.

Dr. Manu Jaggi is a distinguished scientist renowned for his expertise in immunology, particularly in the neuroendocrine axis. With nearly three decades of research experience, his journey seamlessly blends modern scientific exploration with ancient holistic practices. Obtaining his Ph.D. in Cancer Biology from the National Institute of Immunology, New Delhi, in 1994, Dr. Jaggi swiftly transitioned to the pharmaceutical industry, where he amassed over 100 patents and authored 200+ research papers. He has mentored over 500 postgraduates and Ph.D. students and holds memberships in various scientific committees. Dr. Jaggi's pioneering work in preclinical drug development, notably on neuropeptides' role in adenocarcinomas, has reshaped cancer research. His recent focus on biofield energy and holistic wellness has uncovered compelling evidence supporting alternative therapies' efficacy in immunity, aging, and cognitive health.Currently serving as the Chief Operating Officer of Dabur Research Foundation and Althea
Lifesciences, Dr. Jaggi leads a multidisciplinary team dedicated to diverse research domains, including oncology and chronic inflammation. Additionally, he plays key roles as Scientific Mentor at Daivam and Scientific Advisor at Medovie, driving nutraceutical development and traditional medicine applications. Dr. Jaggi's transformative insights have been showcased at many events, where he has emphasized the synergy between ancient wisdom and modern science in holistic well-being. His advocacy for personalized wellness interventions and technological innovations resonated, inspiring a shift towards holistic healing.

Dr. Anu Singh serves as the Chief Operating Officer at Dabur Research Foundation (DRF), India. With a background in signal transduction and neurobiology, Dr. Singh's career trajectory has transited from fundamental pharmaceutical research to significant contributions in the health and wellness sector. She obtained her Ph.D. in Neuroendocrinology from AIIMS Delhi focused on Tumor Biology. Subsequently, she conducted postdoctoral research at the National Institute of Immunology (NII), Delhi, investigating neuropeptide signaling in pancreatic and colorectal cancers. Dr. Singh's pioneering research encompasses the development of sensitive diagnostic methods for thyroglobulin measurement, aiding in early thyroid cancer detection. Dr. Singh's accomplishments include the development and commercialization of nanoparticle-based formulations for treating breast and ovarian cancers. Additionally, she has identified key pathways mediating signal transduction platforms for the gut-brain axis, crucial in understanding optimal longevity, health, and wellness. Heading the R&D team at Dabur Research Foundation, consisting of over 150 scientists, Dr. Singh leads preclinical biology research across diverse therapeutic areas, including oncology, inflammation, metabolic diseases, and cognitive health. Her recent endeavors into human wellness have resulted in the identification of protein biomarkers for quantifying wellness indices, facilitating interventions to enhance health span. She has also made significant contributions to translational biology platforms, aiding in the development of nutraceuticals with measurable efficacy and safety for populations at large. With over 100 international patents, numerous publications, and active involvement in scientific committees, Dr. Singh is a prominent figure in scientific circles and has mentored over 400 postgraduate and PhD students.